Dr. Robert J Jeanfreau
Claim this profileGSK Investigational Site
Studies Migraine Headaches
Studies Migraine
11 reported clinical trials
17 drugs studied
Affiliated Hospitals
Clinical Trials Robert J Jeanfreau is currently running
Lasmiditan
for Pediatric Migraine
The reason for this 12-month, open-label study is to see if the study drug lasmiditan is safe and effective for the intermittent acute treatment of migraine in children aged 6 to 17. The study will last about 12 months and may include up to 7 visits.
Recruiting2 awards Phase 3
Lasmiditan
for Pediatric Migraine
This trial is testing if lasmiditan is safe and effective for children aged 6 to 17 with migraines. The medication aims to block brain signals that cause migraine pain. The study will last several months and may include a few visits. Lasmiditan has been shown to be effective in treating acute migraine attacks in adults and is noted for its safety profile, particularly due to its lack of vasoconstrictive effects.
Recruiting1 award Phase 34 criteria
More about Robert J Jeanfreau
Clinical Trial Related4 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Robert J Jeanfreau has experience with
- Lasmiditan
- NOMAC-E2 COC
- Pegloticase
- GSK3878858A
- RMenB+OMV NZ Vaccine
- MenABCWY-3
Breakdown of trials Robert J Jeanfreau has run
Migraine Headaches
Migraine
Nail Bed Infection
Infections and Infestations
Respiratory Syncytial Virus
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Robert J Jeanfreau specialize in?
Robert J Jeanfreau focuses on Migraine Headaches and Migraine. In particular, much of their work with Migraine Headaches has involved treating patients, or patients who are undergoing treatment.
Is Robert J Jeanfreau currently recruiting for clinical trials?
Yes, Robert J Jeanfreau is currently recruiting for 2 clinical trials in Metairie Louisiana. If you're interested in participating, you should apply.
Are there any treatments that Robert J Jeanfreau has studied deeply?
Yes, Robert J Jeanfreau has studied treatments such as Lasmiditan, NOMAC-E2 COC, Pegloticase.
What is the best way to schedule an appointment with Robert J Jeanfreau?
Apply for one of the trials that Robert J Jeanfreau is conducting.
What is the office address of Robert J Jeanfreau?
The office of Robert J Jeanfreau is located at: GSK Investigational Site, Metairie, Louisiana 70006 United States. This is the address for their practice at the GSK Investigational Site.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.